tiprankstipranks
China Sanjiang Fine Chemicals Co., Ltd. (HK:2198)
:2198
Hong Kong Market
Want to see HK:2198 full AI Analyst Report?

China Sanjiang Fine Chemicals Co., Ltd. (2198) AI Stock Analysis

1 Followers

Top Page

HK:2198

China Sanjiang Fine Chemicals Co., Ltd.

(2198)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
HK$3.00
▼(-4.15% Downside)
Action:Reiterated
Date:05/30/26
The score is held down primarily by elevated financial risk (high leverage and consistently negative free cash flow) and bearish technicals with the stock in a pronounced downtrend. A relatively low P/E provides some valuation support, but it is not enough to outweigh weak cash conversion and negative momentum.
Positive Factors
Profitability Recovery
The company returned to solid profitability in 2024–2025 after the 2022–2023 downturn, indicating operational resilience and cost control. Sustained profits help cover fixed costs, support reinvestment, and improve creditor confidence, giving more durable earnings stability over the next several quarters.
Negative Factors
High leverage
Debt-to-equity above ~2x materially limits financial flexibility and raises refinancing and interest-rate sensitivity. Elevated leverage constrains capacity for capital expenditure, dividend support, or tactical investments, making the firm vulnerable to prolonged commodity downturns or tightening credit conditions.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
The company returned to solid profitability in 2024–2025 after the 2022–2023 downturn, indicating operational resilience and cost control. Sustained profits help cover fixed costs, support reinvestment, and improve creditor confidence, giving more durable earnings stability over the next several quarters.
Read all positive factors

China Sanjiang Fine Chemicals Co., Ltd. (2198) vs. iShares MSCI Hong Kong ETF (EWH)

China Sanjiang Fine Chemicals Co., Ltd. Business Overview & Revenue Model

Company Description
China Sanjiang Fine Chemicals Company Limited functions as an investment holding enterprise within the People's Republic of China, focusing on the production and distribution of a diverse range of chemical products. Its primary offerings include e...
How the Company Makes Money
China Sanjiang Fine Chemicals makes money primarily by manufacturing and selling petrochemical and polyester-chain chemical products to downstream industrial customers. Its core revenue stream is product sales, where revenue is recognized based on...

China Sanjiang Fine Chemicals Co., Ltd. Financial Statement Overview

Summary
Earnings have stabilized versus the 2022–2023 downturn, but 2025 shows revenue decline and margin compression. Financial risk remains elevated due to high leverage (debt-to-equity >~2x) and persistently negative free cash flow, indicating weak cash conversion despite returning profitability.
Income Statement
58
Neutral
Balance Sheet
44
Neutral
Cash Flow
32
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue18.47B19.59B13.13B8.82B9.50B
Gross Profit898.20M1.11B168.77M-70.38M634.52M
EBITDA1.63B1.35B812.91M349.18M388.69M
Net Income407.26M532.55M91.48M-307.88M380.61M
Balance Sheet
Total Assets22.38B22.11B21.00B18.26B14.28B
Cash, Cash Equivalents and Short-Term Investments2.23B888.79M380.05M368.44M851.83M
Total Debt11.82B11.00B10.27B10.52B6.27B
Total Liabilities17.08B17.21B16.64B13.93B9.54B
Stockholders Equity5.32B4.91B4.38B4.30B4.67B
Cash Flow
Free Cash Flow-677.70M-398.88M-1.29B-3.52B-834.29M
Operating Cash Flow912.48M1.06B-122.01M-910.52M1.63B
Investing Cash Flow-1.55B-1.39B-790.28M-1.97B-3.29B
Financing Cash Flow717.35M533.27M1.06B2.50B1.48B

China Sanjiang Fine Chemicals Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.13
Price Trends
50DMA
4.46
Negative
100DMA
4.52
Negative
200DMA
3.58
Negative
Market Momentum
MACD
-0.36
Negative
RSI
29.87
Positive
STOCH
18.26
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2198, the sentiment is Negative. The current price of 3.13 is below the 20-day moving average (MA) of 3.56, below the 50-day MA of 4.46, and below the 200-day MA of 3.58, indicating a bearish trend. The MACD of -0.36 indicates Negative momentum. The RSI at 29.87 is Positive, neither overbought nor oversold. The STOCH value of 18.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2198.

China Sanjiang Fine Chemicals Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
HK$34.91B18.7712.00%0.98%1.21%108.04%
69
Neutral
HK$3.72B9.706.29%6.70%-4.96%15.75%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
HK$1.05B14.982.57%3.52%1.20%-7.22%
49
Neutral
HK$3.52B7.357.74%-5.68%-25.13%
47
Neutral
HK$9.09B-20.36-11.55%77.67%-259.39%
40
Underperform
HK$9.44B144.800.46%1.16%-17.38%224.44%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
3.00
1.28
74.72%
HK:1907
China Risun Group Ltd.
2.12
-0.38
-15.03%
HK:0609
Tiande Chemical Holdings Limited
1.19
0.10
9.17%
HK:0189
Dongyue Group Limited
21.08
11.76
126.13%
HK:6616
Global New Material International Holdings Limited
7.28
2.66
57.58%
HK:0746
Lee & Man Chemical Co. Ltd.
4.51
1.01
28.82%

China Sanjiang Fine Chemicals Co., Ltd. Corporate Events

China Sanjiang Wins Strong Shareholder Backing at AGM, Confirms Dividend and Mandates
May 22, 2026
China Sanjiang Fine Chemicals Company Limited reported that all resolutions at its 22 May 2026 annual general meeting were approved by shareholders through poll voting. Shareholders received and approved the 2025 audited financial statements, re-e...
China Sanjiang Fine Chemicals Sets 2026 AGM to Approve Results and Share Issuance Mandate
Apr 21, 2026
China Sanjiang Fine Chemicals Company Limited has called its annual general meeting for 22 May 2026 in Hong Kong, where shareholders will review and approve the audited consolidated financial statements and reports for the year ended 31 December 2...
China Sanjiang Fine Chemicals Signs Connected Naphtha Supply Deal With Blue Whale Bioenergy
Apr 2, 2026
China Sanjiang Fine Chemicals has moved to secure a stable supply of naphtha feedstock, with subsidiary Sanjiang Chemical signing a purchase agreement with Blue Whale Bioenergy that will run from 2 April 2026 until the end of the year. The arrange...
China Sanjiang Fine Chemicals Updates Final Dividend for 2025
Apr 2, 2026
China Sanjiang Fine Chemicals Company Limited has updated its annual results announcement for the year ended 31 December 2025 to revise details of its final cash dividend. The board now proposes a final ordinary dividend of HKD 0.05 per share, pay...
China Sanjiang Fine Chemicals Proposes HKD 0.5 Final Dividend for 2025
Apr 1, 2026
China Sanjiang Fine Chemicals Company Limited has proposed a final ordinary cash dividend of HKD 0.5 per share for the financial year ended 31 December 2025, subject to shareholder approval on 22 May 2026. The dividend will be paid in Hong Kong do...
China Sanjiang Profit Slides on Margin Squeeze as Group Shifts to Defensive Strategy
Mar 27, 2026
China Sanjiang Fine Chemicals reported that in 2025 its revenue fell 5.7% to RMB18.47 billion, with gross profit down 19.1% and net profit attributable to shareholders down 23.5%, as gross margin narrowed to 4.9%. Profit pressure stemmed mainly fr...
China Sanjiang Unit Bids Up to RMB220 Million for Stake in Ningbo Petrochemical Storage Firm
Mar 27, 2026
China Sanjiang Fine Chemicals’ indirect wholly owned unit Sanjiang Chemical has submitted a public tender to inject up to RMB220 million into Ningbo Xinrun Petrochemical Storage Transportation to acquire a 15%–20% equity stake, paying...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 30, 2026